A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips (4)

A Cancer Diagnosis Is Not The End Of The World – Read These Helpful Tips Most of us thrive on routine and a sense of normality in our lives. This…
Read more
Simple Ways To Manage Cancer (3)

Simple Ways To Manage Cancer There are millions of cases of cancer diagnosed around the world every year. Some are severe and others are definitely curable, but they will all…
Read more
Cancer: Advice On Learning How To Cope (2)

Cancer: Advice On Learning How To Cope If you or a loved one has been diagnosed with cancer, it can be a very scary time. There are so many questions…
Read more
What To Look For When Choosing An Oncologist (2)

What To Look For When Choosing An Oncologist Many of us never actually stop to smell the proverbial roses until we find out that we don’t have a lot of…
Read more
Tips On How To Steer Away From Cancer (5)

Tips On How To Steer Away From Cancer Being able to have a friendly and informative back-and-forth conversation with your doctor is crucial if you want to know your treatment…
Read more

Posts tagged as “UroToday”

Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer. – UroToday

Published 10th August 2020 by admin

Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer. UroToday “prostate cancer” – Google News

Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study. – UroToday

Published 10th August 2020 by admin

Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study. UroToday “prostate cancer” – Google News

PSA-based machine learning model improves prostate cancer risk stratification in a screening population. – UroToday

Published 10th August 2020 by admin

PSA-based machine learning model improves prostate cancer risk stratification in a screening population. UroToday “ovarian cancer” – Google News

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer. – UroToday

Published 10th August 2020 by admin

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer. UroToday “prostate cancer” – Google News

Posts tagged as “UroToday”

Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer. – UroToday

Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study. – UroToday

PSA-based machine learning model improves prostate cancer risk stratification in a screening population. – UroToday

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer. – UroToday

Immune Checkpoint Blockade in Prostate Cancer: It’s All About the Combinations – UroToday

Treatment Considerations for Prostate Cancer Progressing After Combination Therapy for mCSPC – UroToday

ASCO20 Virtual: Biomarkers to Select Patients with Prostate Cancer for PD-1/PD-L1 Blockade – UroToday

Impacts of COVID-19 on Clinical Practice and in Research in Spain – Elena Castro – UroToday

ASCO20 Virtual: Introduction to Theranostics – UroToday

ASCO20 Virtual: Hormonal Therapy for mCSPC: With So Many Options, How Does One Choose? – UroToday

ASCO20 Virtual: Which Patients with mCSPC Should Receive Chemotherapy? – UroToday

ASCO20 Virtual: Recent Advances in Nuclear Medicine Theranostics for Cancer: New Isotopes and Targets – UroToday

ASCO20 Virtual: Choosing a Primary Treatment Modality for High-Risk Localized Prostate Cancer – UroToday

ASCO20 Virtual: Emerging Systemic Treatment Strategies for High-Risk, Clinically Localized Prostate Cancer – UroToday

ASCO20 Virtual: The Current Status of Theranostics in 2020 – UroToday